Jazz Pharmaceuticals PLC
JAZZ
$210.39-2.93%
End of day · as of Oct 14, 2026, 8:00 AM ET
Mkt cap
$14.97B
EV/Sales
4.44
P/E ratio
N/A
FY2025 Revenue
$4.27B
EPS (H1 2026)
$7.17
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-8.35%
Beta
0.33
Div yield
N/A
Sector
Healthcare
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported JAZZ revenue for 2025-12-31 was $4.27B. Net income was -$356.1M. Revenue was up 4.9% from 2024-12-31 to 2025-12-31. JAZZ currently screens at market cap $14.97B.
Use this JAZZ research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full JAZZ income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company in the Healthcare sector.
Latest cached Jazz Pharmaceuticals PLC (JAZZ) revenue for Dec 31, 2025 was $4.27B. Net income was -$356.1M. Statements: https://lician.com/financials/jazz
Jazz Pharmaceuticals PLC (JAZZ) market capitalization is $14.97B on the latest cached snapshot.
Jazz Pharmaceuticals PLC (JAZZ) cached previous close $216.75; day range $210.39 – $216.86; volume 812,985. Session quote: https://lician.com/quote/jazz
Jazz Pharmaceuticals PLC (JAZZ) latest cached earnings event is "JAZZ earnings" on Aug 4, 2026. Earnings calendar: https://lician.com/earnings
The latest cached JAZZ filing is 8-K · Oct 9, 2026. Filings: https://lician.com/sec/jazz